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Background: Iron deficiency is one of the most common nutritional deficiencies worldwide. It is more prevalent
when iron requirements are increased during pregnancy and during growth spurts of infancy and adolescence. The
last stage in the process of iron depletion is characterized by a decrease in hemoglobin concentration, resulting in
iron deficiency anemia. Iron deficiency, even before it is clinically identified as anemia, compromises the immune
response, physical capacity for work, and intellectual functions such as attention level. Therefore, interventions
addressing iron deficiency should be based on prevention rather than on treatment of anemia. The aim of this
study was to compare short- and medium-term effects on ferritin concentration of daily supplementation with
ferrous sulfate or iron bis-glycinate chelate in schoolchildren with iron deficiency but without anemia.
Methods: Two hundred schoolchildren from public boarding schools in Mexico City who had low iron stores as
assessed by serum ferritin concentration but without anemia were randomly assigned to a daily supplement of
30 mg/day of elemental iron as ferrous sulfate or iron bis-glycinate chelate for 12 weeks. Iron status was evaluated
at baseline, one week post-supplementation (short term), and 6 months (medium term) after supplementation.
Results: Ferritin concentration increased significantly between baseline and post-supplementation as well as
between baseline and 6 months after supplementation. One week post-supplementation no difference was found
in ferritin concentration between iron compounds, but 6 months after supplementation ferritin concentration was
higher in the group that received bis-glycinate chelate iron. However, there is no difference in the odds for low iron
storage between 6 months after supplementation versus the odds after supplementation; nor were these odds
different by type of supplement. Hemoglobin concentration did not change significantly in either group after
supplementation.
Conclusions: Supplementing with 30 mg/d of elementary iron, either as ferrous sulfate or iron bis-glycinate chelate
for 90 days, showed positive effects on increasing ferritin concentration in schoolchildren with low iron stores, and
this effect persisted 6 months after supplementation.
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Iron deficiency is one of the most common nutritional
deficiencies worldwide. It is more common when iron
requirements are increased due to the growth spurts of
infancy and adolescence, as well as during pregnancy,
when the fetus derives all its iron stores from the
mother. The last stage in the process of iron depletion is
characterized by a decrease in hemoglobin concentra-
tion, resulting in iron deficiency anemia [1,2]. Anemia is
the result of a negative iron balance that may be due to
any or a combination of the following causes: inadequate
iron intake, impaired or low iron absorption, poor iron
utilization, or increased iron losses, such as chronic
blood loss. In addition to iron deficiency, mineral and
vitamin insufficiencies (e.g., folate, vitamin B12, and vita-
min A), chronic inflammation, parasite infestation, and
hemoglobin (Hb), hereditary disorders can also cause
anemia [1,3,4].
Iron homeostasis results from a complex set of events
that start by absorption of iron by the intestinal cells, its
transport into the cell, and its further release into the
blood stream, where it is transported by means of carrier
proteins (i.e., transferrin), stored in different body stores,
mainly bone marrow, liver, and spleen—known as fer-
ritin complexes—and eventually used in red cell forma-
tion by bone marrow. Therefore, different hematological
markers—the most common of which include ferritin,
serum transferrin, serum transferrin receptors, total
serum iron, number and morphology of red blood cells,
and Hb concentration—may be used to assess iron sta-
tus. Given that Hb depletion represents the last stage in
iron deficiency, Hb concentration is widely used to diag-
nose anemia, while serum ferritin is commonly used as
indicator of iron status in populations [1,5].
Iron deficiency, even before clinically identified as
anemia, compromises the immune response, physical
capacity for work, and intellectual functions such as at-
tention level. This is why children are particularly vul-
nerable to iron deficiency and/or anemia, as they are in
a stage of rapid growth. Therefore, interventions ad-
dressing iron deficiency should be based on prevention
rather than on treatment of anemia [6-8].
The bioavailability and iron absorption from the daily
diet are influenced by the type and quantity of iron
present in food as well as by the presence of inhibitors
and promoters of iron absorption in the diet and the in-
dividual’s iron status [8]. It has been estimated that one-
fifth of the population worldwide has an iron-deficient
diet and that 46% of children between 5 and 14 years are
anemic [1,2,9]. The majority of these children live in de-
veloping countries. In addition, 56% of pregnant women
in developing countries are anemic. Although the precise
estimate of what percentage of anemia is due to iron de-
ficiency, parasitical infections or other deficiencies invitamins, minerals, or nutritious food is not known; it is
estimated that 50% of anemia is due to iron deficiency
[1,2,9].
According to the 2006 National Health and Nutrition
Survey in Mexico (relevant to the time in which the
study was conducted), the prevalence of low iron stores
in 5–11-year-old children nationwide was 13% [10]. In
Mexico City, the prevalence of iron deficiency in chil-
dren 5–11 years old was 4.5%, with a 95% confidence
interval (95% CI) between 2.3 and 8.6, and 11% (95% CI:
7.4 – 14.5) in adolescents 12–14 years old [11]. The
prevalence of anemia according to the 2012 National
Health and Nutrition Survey in Mexico was 10.1% (95%
CI: 9.3 – 10.9) in children 5–11 years old [12]. In
school-aged children, the World Health Organization
recommends doses of 30 mg/day of iron and 250 mg/
day of folic acid for 3 months to prevent iron deficiency
anemia [1,8]. In age 0–13 years, the upper tolerable limit
recommended by the Institute of Medicine in the United
States is 40 mg of elemental iron per day [13]. A recent
Cochrane systematic review of iron supplementation in
children addressed the effects of intermittent oral iron
supplementation versus no supplementation (placebo) in
children under 12 years of age found that iron supple-
mentation improves hematological outcomes. The risk
ratio (RR) of presenting anemia was 0.51 (95% CI: 0.37 –
0.72), while the RR of presenting iron deficiency was
0.24 (95% CI: 0.06 – 0.91), and iron status assess by
serum ferritin showed higher mean levels for those re-
ceiving supplements compared to those receiving no
treatment [1]. It should be noted, however, that most of
the 33 studies included in this review were conducted in
settings with a high prevalence of anemia.
Despite the wide range of pharmaceutical products
available to treat anemia, there have been few studies
about school-age children concerning the effect of pre-
ventive supplementation on nutritional iron status. Fur-
ther, few studies have compared the relative effectiveness
of different iron compounds. Ferrous sulfate is the most
commonly used iron compound in supplementation pro-
grams because of its efficiency and low cost [1,14,15].
Iron bis-glycinate chelate has been proposed as an alter-
native to ferrous sulfate because of its increased bioavail-
ability. Due to its chemical composition, with a ferrous
cation coupled to two glycine molecules, it does not
form insoluble compounds with substances like phytates,
oxalates, and tannins present in high quantity in cereal-
based diets, which have a high content of iron absorp-
tion inhibitors [16-19]. Furthermore, this type of iron
has caused less collateral effects with high doses of
60 mg/d or more of elementary iron [20]. Therefore, in
equal doses, iron bis-glycinate chelate would be expected
to have a larger effect on body iron status compared to
ferrous sulfate [19,21-23]. However, most of the studies
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ventions [19,21-23].
Given that iron supplementation studies have clearly
shown positive effects on treatment of anemia [1,8,9,14,15],
it is important to increase our knowledge on the preven-
tion of iron deficiency anemia. The objective of this study
was to compare the effect on serum ferritin concentration
of daily supplementation with 30 mg of elemental iron as
ferrous sulfate versus iron bis-glycinate chelate in school-
children with iron deficiency but without anemia.
Methods
A randomized, double-blind clinical trial was conducted
between June 2005 and March 2008, enrolling children
aged 5–13 years old from three elementary schools in
Mexico City. This study was carried out with children
from low-income families. All of them attended public
boarding schools where the children remain five days
per week and go home on weekends and vacations. Diets
in participating boarding schools are very similar, as the
menus and food delivered are run from a central facility
and standardized across participating schools.
A sample size was calculated following the rationale
for a bioequivalence study [24]. Based on previous infor-
mation, the probability of success with the administra-
tion of iron sulfate was calculated as 0.81; while success
with iron bis-glycinate was calculated as 0.86, we set the
maximum allowable difference at no more than 0.1. The
calculated sample size rendered 75 children per group,
to which we added an additional 20% for possible attri-
tion, for a final sample size of 90 children per group.
Hb and ferritin concentrations were measured to
screen for potential participants. Children with normal
hemoglobin concentration but with ferritin lower than
the cut-off were considered to have low iron stores but
no anemia and were included in the study. The following
cut-offs were applied: serum ferritin <12 μg/l and Hb ad-
justed for altitude ≥120 g/l for children 12 years or older
and ≥115 g/l for children less than 12 years [8,25]. Chil-
dren with Hb and ferritin lower than the specified cut-
off were considered as having iron deficiency anemia;
they received treatment with the standard oral iron
treatment but were not included in the study.
Study intervention
Children with iron deficiency without anemia were ran-
domly assigned to daily supplements with ferrous sulfate
or bis-glycinate chelate iron (30 mg of elemental iron plus
100 μg of folic acid) for 90 days. Computer-generated ran-
dom numbers (http://www.randomization.com) were used
to assign each child with iron deficiency to either supple-
mentation group. Supplement pills were identical in size,
form, and color, and were coded to preserve blinded
assignment. Supplementation was administered Mondaythrough Friday by trained project staff. The person re-
sponsible for administering the supplement kept a sched-
ule and a registry of which child received the supplement,
according to the random assignment. Compliance was
assessed by means of the daily registration of supplement
administration at school, according to the schedule kept
by project staff responsible for its administration. For
non-school days (i.e., weekends, holidays, or days with
no school attendance), parents were in charge of keep-
ing the schedule and writing down information about
the assigned supplement pill’s administration. This same
schedule included questions related to potential side ef-
fects. All participants received a single 400 mg albenda-
zol dose at the beginning of the study as anti-helminthic
prophylaxis.Biochemical determinations
A venous blood sample was taken by skilled personnel on
three occasions to determine serum ferritin and Hb con-
centrations. The samples were taken at baseline, a week
after completing iron supplementation, and 6 months
after treatment completion (6 months post-treatment).
The sample was taken only if the child did not have a cold
or gastrointestinal infection symptoms (pain, temperature,
cough, vomiting, or diarrhea) the week before. If symp-
toms had been present, blood samples were taken at a
later date. Blood cytology samples were analyzed by cellu-
lar counter (Beckman Coulter, Fullerton, CA). Ferritin was
determined by immune-radiometric assay (Inmunotech
SA, Marseille, France).Anthropometry and diet
All participants were weighed and measured using
standard procedures as suggested by Lohman [26]. Body
mass index (weight in kg/height in m2) was calculated
and children were categorized by age and gender as hav-
ing normal weight, being overweight, or being obese
[27]. The height-for-age z score was calculated and chil-
dren were classified as showing normal nutritional status
(z score ≥ −1) or a slight-to-moderate malnutrition status
(z score < −1) [28].
Semi-quantitative 24-hour recall questionnaires were
used to evaluate the children’s nutrient intake. Standard
portions of the different foods offered at school were
weighed and the ingredients and quantities were re-
corded. Each child was asked how much food he or she
had eaten using a 3-option scale: everything, nothing, or
about half of what was served. Any food eaten by the chil-
dren other than what was offered in school was recorded.
The Mexican Table for Food Equivalence and the Mexican
Food Composition Table [29,30] were used to calculate
the energy and nutrient (protein, carbohydrate, lipids,
iron, and vitamins) intake.
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Sociodemographic information including age, gender,
number of occupants in the dwelling, and parents’ edu-
cation and occupation was collected through a question-
naire given to schoolchildren’s parents or tutors.
Ethical approval
This study was conducted according to the guidelines of
the Declaration of Helsinki and was approved by the Re-
search and Ethics Committees of the Mexican Institute of
Social Security in Mexico City. Written consent was ob-
tained from the participants’ parents or tutors, and written
assent was requested from children older than 7 years.
Statistical analysis
Descriptive statistics were used to describe the baseline
status of the study population. Variables related to iron
nutritional status, Hb, and ferritin concentration were
analyzed using continuous and categorical scales.
The effect of supplementation was evaluated within
and between groups, one week after supplementation
and 6 months after supplementation. Student’s t-test was
used to evaluate the difference in Hb and ferritin con-
centration between groups. Pearson’s Χ2 test was used to
analyze changes in the classification of nutritional iron
status between groups.
Multivariate analyses to evaluate effects of supplemen-
tation on hemoglobin and ferritin concentration during
the study with the two iron compounds were carried out
using mixed-effects linear regression models. The models
were adjusted for fix variable gender and for age as a vari-
able time dependent. Possible interaction between the iron
compound and the time of assessment of the outcome
variables Hb and ferritin concentration were evaluated. As
time of assessment and iron compound interaction was
statistical significance in the model to ferritin concentra-
tion, the mean of ferritin by iron compound and study
stage was described using margins analyses [31].
Mixed-effects logistic regression model was used to
evaluate the risk of having iron deficiency after supplemen-
tation by iron supplementation group adjusting by age, sex,
ferritin, and hemoglobin concentration at baseline.
Values of p < 0.05 were considered statistically signifi-
cant. All data analyses were carried out using Stata 12
SE (Stata Corp., College Station, TX).
Results
A total of 1,020 children were screened, and 200 (19.6%)
who showed low iron stores without anemia were in-
cluded in this study. Children were randomly allocated to
two treatment groups: 101 children received iron bis-
glycinate chelate and 99 children received ferrous sulfate.
A total of 176 children (88%) who received iron sup-
plementation were available for the one-week post-supplementation assessment of iron status. There were
missing values for 14.9% of children who received iron
bis-glycinate chelate, and 9.1% for children who received
ferrous sulfate. Six months after supplementation, there
were samples available for 89 children (44.5% of the total
intervention population). Losses to follow-up at 6 months
after supplementation were 55.4% for the group supple-
mented with bis-glycinate chelate and 55.6% for the
group supplemented with ferrous sulfate (Figure 1). There
were no statistically significant differences between the
baseline characteristics of children who completed the
study and those who were lost to follow-up, except that
children who had missing values 6 months after supple-
mentation were older than children who completed the
study. The age difference was statistically significant for
the iron bis-glycinate chelate group (8.7 ± 1.9 vs. 9.7 ± 2.1,
p = 0.018). Fear and unpleasantness related to taking blood
samples were the most common reasons for children not
to complete the study.
There were no cases in which supplementation had to
be discontinued due to undesirable side effects or
gastrointestinal discomfort. Twenty-two children (10.4%)
had one of the following side effects for one or more
days: diarrhea (n = 3), abdominal pain (n = 15), nausea
(n = 9), constipation (n = 2), or metallic taste (n = 11).
There were no significant differences between the
groups in the presentation of side effects potentially as-
sociated to iron supplementation.
The mean energy intake, after adjusting for age and
sex, was 9188 ± 468 KJ/d. The calorie distribution value
of macronutrient intake was 15.3% from proteins, 56.3%
from carbohydrates, and 27.8% from lipids, and the
mean iron consumption was 11.7 ± 0.7 mg/d. There were
no significant differences in the mean intake of micronu-
trients or iron between supplemented groups.Study population characteristics
The mean age of children with low iron stores was 9.3 ±
1.9 years. The mean of ferritin was 8.7 ± 2.1 μg/l. The
mean of Hb was 140 ± 9.1 g/l. There were no significant
statistical differences in the sociodemographic or nutri-
tional characteristics between supplementation groups
(Table 1).Descriptive results: serum ferritin and hemoglobin
concentration
During the follow-up, there was a statistically significant
positive effect of supplementation on ferritin concentra-
tion and on the classification of iron status. At baseline,
all schoolchildren had low iron storages as evaluated by
ferritin concentration; one week after supplementation
and 6 months post-supplementation, only 10% of chil-
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Figure 1 Study population. Flow of participants through the trial.








n % n % n %
Sex
Male 91 45.5 42 41.6 49 49.5
Female 109 54.5 59 58.4 50 50.5 0.261
Age (years)b 9.3 1.9 9.3 2.1 9.4 1.7 0.728
Height for agec
Normal 136 69.1 72 72.7 64 66.0
Low or moderate malnutrition 60 30.6 27 27.3 33 34.0 0.305
Body mass indexd
Normal 147 73.0 70 70.7 73 75.3
Overweight or obese 53 27.0 29 29.3 24 24.7 0.473
Mother’s schooling
High school or more 60 32.3 30 31.9 30 32.6
Middle school or less 126 67.7 64 68.1 62 67.4 0.919
Hemoglobin concentration (g/l)b 140.9 9.1 141.6 10.3 140.2 7.6 0.273
Ferritin concentration (μg/l)b 8.7 2.1 8.7 2.1 8.9 2.1 0.548
aPearson’s X2 test.
bMean and standard deviation. Student’s t test.
cWHO’s reference population, 2007 [28].
dCole et al. Cut-off point by age and sex [27].
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Table 2 Comparison of nutritional iron status at baseline and during the follow-up by iron compound supplement
Baseline Post-supplementation 6 months after supplementation



















Hemoglobin concentration (g/l)a 141.6 140.2 141.7 140.1 141.7 139.8
Standard deviation 10.3 7.6 0.273b 8.2 7.5 0.175b 7.3 6.9 0.205b
Ferritin concentration (μg/l)a 8.7 8.9 29.6 28.9 31.0 25.2
Standard deviation 2.1 2.1 0.548b 15.1 13.1 0.728b 18.7 12.5 0.090b
Iron nutritional statusc
Low iron stores 101 100 99 100 9 10.5 6 6.7 5 11.1 4 9.1
Normal 0 0.0 0 0.0 – 77 89.5 84 93.3 0.367d 40 88.9 40 90.9 0.752d
aMean and standard deviation.
bStudent’s t test.
cLow iron stores = Serum ferritin <12 μg/l.
dPearson’s Χ2 test.
Duque et al. Nutrition Journal 2014, 13:71 Page 6 of 10
http://www.nutritionj.com/content/13/1/71Effects on ferritin and hemoglobin concentration and on
the risk of having iron deficiency
Multivariate analysis on the effect of supplementation on
ferritin concentration after adjusting by age at the time of
each biochemical determination and by sex showed the
following: 1: Compared to baseline ferritin concentration,
the children had a change of 20.16 μg/l one week post-
supplementation and a change of 16.43 μg/l 6 months after
supplementation. 2: The effect was statistically different be-
tween iron compounds only at 6 months after supplemen-
tation. The group that received bis-glycinate chelate iron
showed 6.04 μg/l higher ferritin concentration in compari-
son to the group with ferrous sulfate supplementation,
p = 0.028 (Table 3, Figure 2). The adjusted ferritin concen-
tration one week post-supplementation, based on the model
shown in Table 3, was estimated to be 28.9 μg/l (95% CI:
26.6 – 31.2) and 6 months after supplementation of
25.2 μg/l (95% CI: 21.9 – 28.5) in the group that receivedTable 3 Effects on mean concentration of ferritin according to







6 months after supplementation
Additional increment in the group supplemented with Bis-glycinate ch
At baseline
One week post-supplementation
6 months after supplementation
Mixed-effects linear regression model with random intercept, adjusted by age and
group: 2.3 (1–3).
Ref. = Reference value.
aInteraction between study stage and iron compound (bis-glycinate chelate vs. ferroferrous sulfate, and of 29.6 μg/l (95% CI: 27.3 – 32.0) and
31.1 μg/l (95% CI: 27.8 – 34.3), respectively, in the group
that received bis-glycinate chelate (Figure 2). No signifi-
cant effect was observed in Hb concentration (Table 4).
There were no differences between the odds of having
low iron storages either in the group with iron bis-glycinate
chelate versus the group that received ferrous sulfate,
OR 1.40 (CI 95%, 0.58 – 3.42) either at 6 months post-
supplementation versus one week post-supplementation,
OR 1.40 (CI 95%, 0.56 – 3.49), after adjustment for age,
sex, ferritin, and hemoglobin concentration at baseline
(Table 5).
Discussion
Our results showed that 90 days of supplementation
with 30 mg/day of elemental iron as either ferrous sul-
fate or iron bis-glycinate chelate had a positive effect on
raising ferritin concentration in school-age children withiron compound and time of evaluation
Change in mean of ferritin (μg/l) 95% CI P value
Ref.
−0.18 −3.26 – 2.91 0.909
Ref.
20.16 17.11 – 23.22 0.001
16.43 12.57 – 20.28 0.001
elatea
Ref.
0.87 −3.45 – 5.19 0.694
6.04 0.64 – 11.43 0.028
sex. Number of observations: 465, number of groups: 200, observations per
























Baseline Post-supplementation 6 months after
supplementation
Study stage
Ferrous sulfate Bis-glycinate chelate
Figure 2 Predicted ferritin concentration (μg/l) by iron compound and time of evaluation. Results are based on the model shown
in Table 3.
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supplementation and was still present 6 months after
supplementation. Furthermore, the bis-glycinate chelate
compound was more efficient for maintaining higher fer-
ritin concentration 6 moths after supplementation than
ferrous sulfate. Persistence of the observed effect for this
long period after supplementation may be explained by
the effect of a diet that may provide enough bioavailable
iron to maintain iron status once the initial deficit was
overcome. Actually, the effect of iron bis-glycinate che-
late may be larger where individuals consume a typical
Mexican diet (as do families with low incomes, such as
the ones included in this study), which includes phytic
acid from cereals (i.e., maize) and legumes (i.e., beans).
This compound binds iron, reducing its bioavailability
for intestinal absorption.
In a longitudinal study about iron deficiency due to
consumption of low bioavailable iron diet in Africa by
schoolchildren with normal iron status after a fortifica-
tion intervention, after 15 months the authors found a
mean change in total body iron stores of −142 mg, and
estimated a 2% mean iron absorption of dietary iron.Table 4 Effects on mean concentration of hemoglobin (g/l) ac






One week post-supplementation −0.11
6 months after supplementation −0.46
Mixed effects linear regression model with random intercept, adjusted by sex and a
group: 2.3 (1–3).Hemoglobin decreased by 12 g/l, and 75% of the cohort
had deficit in tissue iron. The authors concluded that
low iron bioavailability from a legume- and cereal-based
diet is a cause of iron deficiency anemia in children in
rural Africa [32]. In our study, there were no differences
in the odds of having low iron storages between the two
iron compounds at either evaluation period. This could
mean that the higher ferritin concentration at 6 months
post-supplementation in the bis-glycinate chelate group
versus ferrous sulfate group had no clinical implication.
Our findings concurred with other studies carried out
on pregnant women, adolescents, school-age children, and
preschool children in which both ferrous sulfate and iron
bis-glycinate chelate were found to be equally effective
[20,33]; however, in those studies, the effects 6 months
post-supplementation had not been evaluated. Results of a
systematic review and meta-analysis on iron supplementa-
tion on children, that included 32 studies including 7,089
children aged 5–12 years; 31 of these studies were con-
ducted in lower- or middle-income countries [9] and
showed that iron supplementation improves hematologic
and non-hematologic outcomes. Iron supplementationcording to iron compound and time of evaluation
an Hb 95% CI P value
−0.20 – 3.63 0.080
−1.36 – 1.13 0.859
−2.08 – 1.16 0.578
ge. Number of observations: 469, number of groups: 200, observations per
Table 5 Association between iron compound at time of
evaluation and low iron storages
Supplement and time of evaluation OR 95% CI P value
Supplement
Ferrous sulfate Ref.
Bis-glycinate chelate 1.40 0.58 – 3.42 0.452
Time of Evaluation
One week post-supplementation Ref.
6 months after supplementation 1.40 0.56 – 3.49 0.465
Ref. = Reference value.
Mixed effects logistic regression model with random intercept, adjusted by
sex, age; ferritin and hemoglobin concentration at baseline. Number of
observations: 265, number of groups: 180, observations per group: 1.5 (1–2).
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duced the prevalence of iron deficiency by 79%; there was
also evidence of a benefit on cognitive performance in
children with anemia at baseline [9]. The increase in
hemoglobin or ferritin concentrations is related to iron
status at baseline, dose of iron, and length of time of sup-
plementation [3,34,35]. However, most studies have fo-
cused on treating anemia more than on treating the iron
deficiency to prevent iron deficiency anemia.
In a supplementation study carried out in Brazil that
compared administration of ferrous sulfate (40 mg of
iron per week) versus iron bis-glycinate chelate (3.8 mg
per week as bis-glycinate chelate-enriched cookies) for
8 weeks on schoolchildren with anemia, the authors re-
ported a significant increase in Hb concentration but
no significant difference in the inter-group comparison.
No effect was observed on serum ferritin for either
intervention, but children with depleted iron stores
(ferritin <15 ng/mL) at the beginning of the intervention
showed increased serum ferritin concentration, although
no difference between treatments was observed [33].
Ribeiro and Sigulem supplemented anemic children
between 6 and 36 months with 5 mg/kg/d of iron as bis-
glycinate chelate [36] and found a significant increase in
the Hb concentration; however, ferritin concentration
was not measured. Pineda and Ashmead supplemented
children with anemia and malnutrition between 6 to
36 months of age with ferrous sulfate versus iron bis-
glycinate chelate offering 5 mg/kg/d for 28 days. This
study showed a significant increase in Hb and ferritin
concentration in both supplemented groups. The differ-
ence in Hb concentration between the two groups post-
intervention was not statistically significant; however,
the difference in the serum ferritin concentration was
significantly higher in the group that received iron bis-
glycinate chelate [37]. In summary, these studies show a
positive effect of supplementation with ferrous sulfate
and of supplementation or food fortification with ferrous
bis-glycinate chelate on treating anemia, but we foundno published study that focused on preventing iron defi-
ciency anemia in schoolchildren population that in-
cluded the bis-glycinate chelate iron compound.
As mentioned, iron bis-glycinate chelate has been used
for food enrichment and for supplementation. Due to its
chemical structure (consisting of a covalently bounded
iron molecule to an organic ligand, in this case glycine),
this form of iron can be partially resistant to the action of
enzymes and to the binding action of substances naturally
present in food such as metals, dietary fiber, phytates, and
phenols, with which the iron can form insoluble com-
pounds. In addition, because of the amino acid bonding,
there is less direct exposure of iron to the gastrointestinal
mucosa cells; this can reduce local toxicity and side effects
attributable to iron compounds present in the intestinal
lumen, like abdominal pain [18,19,33,37,38]. In various
supplementation studies, correlations have been noted be-
tween the doses of iron given and/or the chemical formula
used and side effects. The most common side effects asso-
ciated with iron supplementation affect the gastrointes-
tinal tract, manifesting as constipation, nausea, diarrhea,
and vomiting [1,3,36,38].
Coplin et al. compared the tolerability of ferrous sulfate
and iron bis-glycinate chelate in a study. They found that
both ferrous sulfate and iron bis-glycinate chelate had
equivalent therapeutic efficiency at a similar dosage
(50 mg), but the side effects were greater (37% vs. 21%) in
the group that received ferrous sulfate [20]. Gastrointes-
tinal complaints and symptoms as constipation, nausea,
vomiting, and diarrhea have been observed commonly in
women consuming high doses of supplemental iron. The
frequency and intensity of these complains are related to
the amount of elemental iron released in the stomach
[1,39]. In malaria areas, additional iron may exacerbate
malaria infection. For theses reasons, iron supplementa-
tion programs should be supervised and planned accord-
ing to target the population [1].
In a systematic review, Low et al. evaluated the benefits
and safety of daily iron supplementation in school-aged
children. There was no difference in the frequency of chil-
dren with gastrointestinal upset, constipation, vomiting,
or diarrhea between children who received iron supple-
mentation and children in the placebo group. The authors
concluded that iron supplements appeared to be well tol-
erated, but the safety dates were limited: only 6 of 32 stud-
ies reported safety outcomes [9]. In our study, there were
few gastrointestinal side effects with either treatment, so
there was no need to suspend supplementation. Moreover,
there were no differences in the observation of gastro-
intestinal side effects between the two supplementation
groups. This lack of significant side effects may have been
due to the low dose of iron given (30 mg/d).
We recognize some caveats of our study. In terms of
design, a more comprehensive description of iron status
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tus, such as serum transferrin, serum transferring recep-
tors, and total serum iron. Likewise, indicators of
infection as C reactive protein and α1-glycoprotein have
been evaluated in some studies on iron supplementation.
However, serum ferritin has been considered a good in-
dicator of iron storage and is useful in evaluating inter-
ventions response at a population level [2].
While serum concentrations of this protein can be in-
creased during inflammatory and infectious processes as
well as in response to trauma, children participating in
our study received anti-helminthic prophylaxis at the be-
ginning of the study, and the blood sample was obtained
only if the children did not have a cold, fever, or any
other common symptom of infection, so we consider
that the use of serum ferritin in this study was a good
indicator of iron storage as well as a good indicator of
intervention response at the population level, as has
been suggested [5]. In terms of implementation, the main
constraint of our study was related to the high attrition
rate to effect evaluation at 6 months after supplementa-
tion. However, the only difference between participants
who completed the study and the ones missing data dur-
ing follow-up was age, and the results of our multivariate
analyses were adjusted by age as soon as each evaluation
of iron status was done. Therefore, we do not think that
this attrition reflected a selection bias that could substan-
tially bias our results.
Conclusions
The results of our study showed that a low iron dose of
30 mg/day for 90 days with either ferrous sulfate or iron
bis-glycinate chelate significantly increased serum fer-
ritin concentration in schoolchildren with low iron
stores but no anemia and had negligible side effects. The
effect on increased iron status was sustained up to
6 months after supplementation, rendering both treat-
ments as safe and effective. These results support the
preventive effectiveness of this low-dose iron interven-
tion to increase serum ferritin, which will help prevent
iron deficiency anemia and may be relevant where iron
deficiency is a public health concern and where a pre-
ventive daily low dosage of iron supplementation can be
used to help the school-age population maintain an ad-
equate nutritional iron status.
We recognize upfront, however, that iron supplemen-
tation is no substitute for a balanced diet and that in
areas where parasitic infections are prevalent, these
should be treated as part of a comprehensive approach
to improve iron status. Furthermore, where malaria is
endemic, we would caution against extended use of iron
supplementation, even in small doses, until safety studies
have been conducted. In these areas, the World Health
Organization recommends to first treat the infection,and then to provide iron supplementation. In summary,
while our results support that low daily doses of ferrous
sulfate or bis-glycinate chelate iron can be utilized to
prevent iron deficiency anemia in schoolchildren with
iron deficiency, prevention and control of anemia are
complex and, depending on the setting, may require
the implementation of a comprehensive set of control
measures [40].
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